Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Legal Issues Author: Kara Brandeisky Last Updated: Mar 12, 2014 - 6:21:32 PM



Drug Company Agrees to Pay $27.6 Million to Settle Allegations Involving Chicago Psychiatrist

By Kara Brandeisky
Mar 12, 2014 - 6:16:44 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - Teva Pharmaceutical Industries Ltd. has agreed to pay more than $27.6 million to settle state and federal allegations that it induced Chicago psychiatrist Michael Reinstein to overprescribe clozapine, a powerful antipsychotic drug.

Reinstein has twice figured into ProPublica investigations.


 

 

<script type="text/javascript" src="http://pixel.propublica.org/pixel.js" async="true"></script>

Four years ago, ProPublica and the Chicago Tribune spotlighted Reinstein's prescribing pattern, findingthat in 2007 he had prescribed more clozapine to patients in Medicaid's Illinois program than all of the doctors in the Medicaid programs of Texas, Florida and North Carolina combined. At least three of Reinstein's patients died of clozapine intoxication. At that time, Reinstein defended his prescription record, arguing that clozapine is effective and underprescribed.

Then, last spring, ProPublica reported that Reinstein prescribed even more of the drug in Medicare's prescription drug program for seniors and the disabled. ProPublica cited Reinstein in an investigation about how Medicare fails to monitor problem prescribers, finding that the program continued to let him prescribe even after federal prosecutors accused him of fraud and Illinois' Medicaid program suspended payments to him.

Generic clozapine, an anti-schizophrenia drug manufactured by Teva, is approved to treat cases that don't respond to other medications. But clozapine can have dangerous side effects, including seizures, inflammation of the heart muscle and a drop in white blood cells. The drug is considered to be particularly dangerous for elderly patients.

Illinois Attorney General Lisa Madigan and the U.S. Justice Department claimed that IVAX, a Teva Pharmaceuticals subsidiary, paid Reinstein to overprescribe clozapine to Medicare and Medicaid patients. Yesterday Teva agreed to pay almost $15.5 million to the federal government and more than $12.1 million to Illinois to settle those allegationsout of court. Teva spokeswoman Denise Bradley told Reuters that the settlement does not mean that the company has admitted any liability.

"Pharmaceutical companies must not be allowed to improperly influence physicians' decisions in prescribing medication for their patients," Zachary T. Fardon, U.S. Attorney for the Northern District of Illinois, said in a statement on Tuesday. "Instead, those decisions must be made solely on the basis of the patient's best medical interests."

In November 2012, federal prosecutors also filed suit against Reinstein, alleging that IVAX hadpaid him $50,000 a year to work as a consultant, paid his nurse to promote the drug and funded a study at an affiliated research institute. After the payments, Reinstein began overprescribing clozapine. The company also allegedly paid for trips and entertainment for Reinstein and his friends.

The suit against Reinstein is still pending. Reinstein's attorney did not immediately respond to request for comment.

###

For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.

 



Top of Page

HealthNewsDigest.com

Legal Issues
Latest Headlines


+ Healthcare Law Firm Expands into Northeast and West
+ FTC Alleges Debt Brokers Illegally Exposed Personal Information of Tens of Thousands of Consumers on the Internet
+ FTC Approves Final Orders Banning Two Companies From Making Unsubstantiated Slimming Claims for Shapewear Undergarments
+ Health Law? What Health Law?
+ Court Shuts Down New York-Based Tech Support Scam Business
+ Avoiding Medicare Scams
+ Court Stops Supplement Marketers From Deceptive Advertising and Illegally Debiting Consumers’ Accounts
+ FTC Stops Marketers of Phony Health Care ‘Discount’ Schemes Directed at Older Americans and Spanish-Speaking Consumers
+ FTC Settlement Bans Marketer Behind ‘Fat Burner’ Diet Pills from Manufacturing, Marketing Weight-Loss Products
+ Entrepreneurs and Investors Interested in Florida's Medical Marijuana Industry Demand Insights into Florida's Regulatory Approach



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions